Home Cart Sign in  
Chemical Structure| 6724-53-4 Chemical Structure| 6724-53-4

Structure of Perhexiline maleate
CAS No.: 6724-53-4

Chemical Structure| 6724-53-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Perhexiline is a carnitine palmitoyltransferase 1 (CPT1) and CPT2 inhibitor that was originally developed as an anti-anginal drug.

Synonyms: Perhexiline (maleate)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Perhexiline maleate

CAS No. :6724-53-4
Formula : C23H39NO4
M.W : 393.56
SMILES Code : O=C(O)/C=C/C(O)=O.C1(CC(C2CCCCC2)C3CCCCC3)NCCCC1
Synonyms :
Perhexiline (maleate)
MDL No. :MFCD00057329

Safety of Perhexiline maleate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Description
Perhexiline maleate, an orally active inhibitor of CPT1 and CPT2, curtails fatty acid metabolism and induces mitochondrial dysfunction and apoptosis in hepatic cells. It can cross the blood-brain barrier (BBB) and exhibits anti-tumor properties. Perhexiline maleate is researched for its potential therapeutic applications in cancer and cardiovascular diseases such as angina[1].[2].[5].

In Vitro:

Cell Line
Concentration Treated Time Description References
OVCAR-5/RFP 4 µM 10 days To evaluate the killing effect of Perhexiline on ovarian cancer MRD cells, results showed that Perhexiline had a more pronounced killing effect on MRD cells in 3D microtumors than in 2D cultures. Adv Healthc Mater. 2025 May;14(14):e2404072
OVCAR5 4 µM 10 days To evaluate the killing effect of Perhexiline on ovarian cancer MRD cells, results showed that Perhexiline had a more pronounced killing effect on MRD cells in 3D microtumors than in 2D cultures. Adv Healthc Mater. 2025 May;14(14):e2404072
HepG2 cells 10 µM 24 hours To investigate the effect of perhexiline on ApoA-I production, it was found that perhexiline significantly increased ApoA-I production J Clin Invest. 2015 Oct 1;125(10):3819-30
Mouse pancreatic organoids (KPSC) 4 µM 48 hours Inhibits growth and induces apoptosis in KPSC organoids Cell Stem Cell. 2024 Jan 4;31(1):71-88. e8
Human PDAC organoids (WCM744 and WCM773) 4 µM 72 hours Inhibits growth and induces apoptosis in human PDAC organoids Cell Stem Cell. 2024 Jan 4;31(1):71-88. e8

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Endotoxemia and sepsis models Intragastric administration 10 mg/kg Once per 12 hours, twice Perhexiline activated the expression of KLF14, significantly prolonged the survival rate of mice with LPS-induced endotoxemia and CLP-induced sepsis, and reduced lung tissue injury. Cell Mol Immunol. 2022 Apr;19(4):504-515
Mice High-fat diet-induced atherosclerosis model Gavage 10 mg/kg/d 5 consecutive days To evaluate the effect of perhexiline on HDL-C and ApoA-I levels, it was found that perhexiline significantly increased HDL-C and ApoA-I levels J Clin Invest. 2015 Oct 1;125(10):3819-30
Nude mice KPSC organoid xenograft model Intraperitoneal injection 16 mg/kg Every other day for 4 weeks Significantly inhibits the growth of KPSC xenografts Cell Stem Cell. 2024 Jan 4;31(1):71-88. e8

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02431221 Hypertrophic Cardiomyopathy Phase 3 Withdrawn(Lack of efficacy in ... More >>a preceding study.) Less << - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.54mL

0.51mL

0.25mL

12.70mL

2.54mL

1.27mL

25.41mL

5.08mL

2.54mL

References

 

Historical Records

Categories